General Information of the Compound
| Compound ID |
CP0962459
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-4-Chloro-7-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-9-(2,2,2-trifluoro-ethyl)-6,7,9,10-tetrahydro-3H-1,3,9-triaza-cyclohepta[e]inden-8-one
Show/Hide
|
||||||||||||||||||
| Formula |
C29H30ClF3N6O3
|
||||||||||||||||||
| Molecular Weight |
603.045
|
||||||||||||||||||
| Canonical SMILES |
O=C(C[C@@H]1Cc2cc(Cl)c3[nH]cnc3c2CN(CC(F)(F)F)C1=O)N1CCC(N2CCc3ccccc3NC2=O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H30ClF3N6O3/c30-22-12-18-11-19(27(41)38(15-29(31,32)33)14-21(18)25-26(22)35-16-34-25)13-24(40)37-8-6-20(7-9-37)39-10-5-17-3-1-2-4-23(17)36-28(39)42/h1-4,12,16,19-20H,5-11,13-15H2,(H,34,35)(H,36,42)/t19-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LAZILMAWWFHXME-IBGZPJMESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound